Get started
Author

Paniz Khooshemehri

Observed name: P. Khooshemehri
OpenAlex ID: A5043579437
Clinical and Biological Remission With Tezepelumab: The Real‐World Response in Severe Uncontrolled Asthma
2025 · Jessica Gates, Faizan Haris, et al. · Allergy · 54
PDF
The RNA binding proteins ZFP36L1 and ZFP36L2 modulate transcriptional and post-transcriptional genome-wide effects of glucocorticoids
2022 · Jennifer Rynne, Elena Ortiz-Zapater, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 4
PDF
Genetic Polymorphism of Mismatch Repair Genes and Susceptibility to Prostate Cancer.
2020 · Paniz Khooshemehri, Seyed Hamid Jamaldini, et al. · Urology journal./Urology jornal. · 4
PDF
Fractional exhaled nitric oxide as a novel biomarker of relapse in eosinophilic granulomatosis with polyangiitis
2026 · Francesca Cefaloni, Anne-Catherine Maynard-Paquette, et al. · American Journal of Respiratory and Critical Care Medicine · 2
IGF2BP3 inhibits IL-13 and IL-4 effects in human airway epithelium and is dysregulated in type 2 disease
2025 · Paniz Khooshemehri, Onofrio Zanin, et al. · bioRxiv (Cold Spring Harbor Laboratory) · 1
PDF
Fraction Exhaled Nitric Oxide as a Novel Biomarker of Relapse in Eosinophilic Granulomatosis With Polyangiitis
2025 · F. Cefaloni, A.-C. Maynard-Paquette, et al. · American Journal of Respiratory and Critical Care Medicine · 1
Late Breaking Abstract - The impact of benralizumab on FeNO in severe asthma is associated with bronchial epithelial phenotype and is independent of local eosinophil depletion
2026 · Jessica Gates, Jiashu Shen, et al. · European Respiratory Journal
Late Breaking Abstract - Investigating the inflammatory profile of exacerbations in patients with severe asthma receiving tezepelumab: the phase IV TezEx study
2026 · Faizan Haris, Francesca Cefaloni, et al. · European Respiratory Journal
Late Breaking Abstract - Beyond the Eosinophil: Benralizumab Drives Coordinated CD4+ T Cell Immune Remodelling in Severe Eosinophilic Asthma
2026 · Jessica Gates, Paniz Khooshemehri, et al. · European Respiratory Journal
Late Breaking Abstract - Eosinophil depletion unmasks distinct cytokine profiles in EGPA and severe eosinophilic asthma
2026 · Paniz Khooshemehri, Jessica Gates, et al. · European Respiratory Journal
Clinical characteristics associated with frequent asthma exacerbations whilst on treatment with tezepelumab
2025 · Faizan Haris, Jessica Gates, et al. · European Respiratory Journal
The relationship between atopy, IgE levels and response to tezepelumab in severe asthma
2025 · Francesca Cefaloni, Jessica Gates, et al. · European Respiratory Journal
Characterizing exacerbations in severe asthma patients treated with tezepelumab
2025 · Faizan Haris, Raphael Birch, et al. · European Respiratory Journal
KCL TEST: an open-source inspired asymptomatic SARS-CoV-2 surveillance programme in an academic institution
2024 · Joana Reis de Andrade, Edward Scourfield, et al. · Biology Methods and Protocols
The role of IGF2BP3 in Type 2 signalling in bronchial epithelium: a novel player in severe asthma
2022 · Paniz Khooshemehri, Rocio T Martinez-Nunez
Alveolar macrophages from people with severe eosinophilic asthma show differential antiviral responses to human rhinovirus 16 and SARS-CoV-2.
2022 · Andrew Hearn, Paniz Khooshemehri, et al.
Modulation of antiviral responses to rhinovirus by the nonsense mediated decay pathway and implications in rhinovirus-induced exacerbations
2022 · Adam Richardson, Nicole Ponde, et al.
The RNA binding proteins ZFP36L1 and ZFP36L2 exert genome-wide effects on airways epithelium and glucocorticoid responses
2022 · Jennifer Rynne, Elena Ortiz-Zapater, et al.
Works count: 18
Citation count: 66
H-index: 3
I10-index: 1
Year
Topic
Type